NAVIDEA BIOPHARMACEUTICALS, INC.: 10-Q filed 2016-11-09

Name: NAVIDEA BIOPHARMACEUTICALS, INC.: 10-Q filed 2016-11-09
Creator: NAVIDEA BIOPHARMACEUTICALS, INC.
License: https://creativecommons.org/licenses/by/4.0/

What NAVIDEA BIOPHARMACEUTICALS, INC. reported in its quarterly report filed 2016-11-09 (fiscal Q3 2016): 34 published measures, 90 facts as tagged in accession 0001564590-16-028688.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-11-09
Fiscal period: fiscal Q3 2016
Accession: 0001564590-16-028688 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All NAVIDEA BIOPHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	11,189,600	USD
At 2015-12-31	14,964,513	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-09-30	74,964,201	USD
At 2015-12-31	68,800,213	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	-64,243,643	USD
At 2015-12-31	-54,305,258	USD

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	1,847	USD	92
2016-01-01 to 2016-09-30	1,847	USD	274
2015-07-01 to 2015-09-30	2,788	USD	92
2015-01-01 to 2015-09-30	30,406	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	8,497,074	USD	92
2016-01-01 to 2016-09-30	18,614,109	USD	274
2015-07-01 to 2015-09-30	3,979,277	USD	92
2015-01-01 to 2015-09-30	8,955,641	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-390,973,227	USD
At 2015-12-31	-380,546,651	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-09-30	1,374,074	USD
At 2015-12-31	1,927,608	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	50,000	USD	92
2016-01-01 to 2016-09-30	310,642	USD	274
2015-07-01 to 2015-09-30	397,000	USD	92
2015-01-01 to 2015-09-30	1,916,179	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	3,358,431	USD	92
2016-01-01 to 2016-09-30	209,895	USD	274
2015-07-01 to 2015-09-30	-4,323,077	USD	92
2015-01-01 to 2015-09-30	-15,949,829	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	9,430,861	USD
At 2015-12-31	12,577,174	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	63,763,839	USD
At 2015-12-31	6,183,850	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-09-30	4,894,800	USD
At 2015-12-31	1,767,523	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2016-09-30	180,986	USD
At 2015-12-31	186,158	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	4,216,826	USD	92
2016-01-01 to 2016-09-30	16,386,728	USD	274
2015-07-01 to 2015-09-30	7,844,764	USD	92
2015-01-01 to 2015-09-30	23,666,093	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2016-09-30	804,882	USD
At 2015-12-31	652,906	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	7,575,257	USD	92
2016-01-01 to 2016-09-30	16,596,623	USD	274
2015-07-01 to 2015-09-30	3,521,687	USD	92
2015-01-01 to 2015-09-30	7,716,264	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	2,940,773	USD	92
2016-01-01 to 2016-09-30	9,925,574	USD	274
2015-07-01 to 2015-09-30	3,942,609	USD	92
2015-01-01 to 2015-09-30	13,485,576	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	1,276,053	USD	92
2016-01-01 to 2016-09-30	6,461,154	USD	274
2015-07-01 to 2015-09-30	3,902,155	USD	92
2015-01-01 to 2015-09-30	10,180,517	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	155,751,316	shares
At 2015-12-31	155,649,665	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-09-30	326,573,833	USD
At 2015-12-31	326,085,743	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	-63,774,601	USD
At 2015-12-31	-53,835,700	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-09-30	3,584,628	USD
At 2015-12-31	3,871,035	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-09-30	2,210,554	USD
At 2015-12-31	1,943,427	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2016-09-30	203,679	USD
At 2015-12-31	273,573	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2016-09-30	624,896	USD
At 2015-12-31	1,677,633	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-09-30	839,978	USD
At 2015-12-31	1,054,822	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-59,536	USD	92
2016-01-01 to 2016-09-30	-10,427,092	USD	274
2015-07-01 to 2015-09-30	-8,071,104	USD	92
2015-01-01 to 2015-09-30	-25,053,248	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-59,377	USD	92
2016-01-01 to 2016-09-30	-10,426,576	USD	274
2015-07-01 to 2015-09-30	-8,070,764	USD	92
2015-01-01 to 2015-09-30	-25,098,567	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	378,834	USD	274
2015-01-01 to 2015-09-30	431,368	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-12,498	USD	92
2016-01-01 to 2016-09-30	-49,916	USD	274
2015-07-01 to 2015-09-30	4,402	USD	92
2015-01-01 to 2015-09-30	26,100	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	140	USD	274
2015-01-01 to 2015-09-30	65,975	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-210,536	USD	274
2015-01-01 to 2015-09-30	1,108,828	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	195,330	USD	274
2015-01-01 to 2015-09-30	83,712	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	3,212,632	USD	274
2015-01-01 to 2015-09-30	-178,620	USD	273

Inspect the source

Entity: NAVIDEA BIOPHARMACEUTICALS, INC. / CIK 0000810509
Captured: 2026-09-22 19:30 UTC
SEC response SHA-256: e6e15b291454205779be87d7d17e86894a378fd299b7dd1312591814ed2d7c83

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000810509.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))